Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00848926 · FLOW

Participant flow

A Pivotal Open-Label Trial of Brentuximab Vedotin for Hodgkin Lymphoma · Source last updated 2017-03-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Brentuximab vedotin 1.8 mg/kg every 3 weeks by intravenous (IV) infusion
    id
    FG000
    title
    Brentuximab Vedotin
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        45
      type
      Progressive disease
    2. reasons
      1. group Id
        FG000
        num Subjects
        20
      type
      Adverse Event
    3. reasons
      1. group Id
        FG000
        num Subjects
        12
      type
      Physician Decision
    4. reasons
      1. group Id
        FG000
        num Subjects
        7
      type
      Withdrawal by Subject
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        102
      type
      STARTED
    2. achievements
      1. comment
        Number who completed 16 cycles of treatment
        group Id
        FG000
        num Subjects
        18
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        84
      type
      NOT COMPLETED
    title
    Treatment Period
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        7
      type
      Lost to Follow-up
    2. reasons
      1. group Id
        FG000
        num Subjects
        3
      type
      Withdrawal by Subject
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Other
    milestones
    1. achievements
      1. comment
        All participants were to be followed after treatment
        group Id
        FG000
        num Subjects
        102
      type
      STARTED
    2. achievements
      1. comment
        Completed survival follow-up due to death \[57\] or study termination by sponsor \[33\]
        group Id
        FG000
        num Subjects
        90
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        12
      type
      NOT COMPLETED
    title
    Follow-up Period
recruitment Details
Enrollment period: Feb 2009 - Aug 2009
Complete source fields
groups
  1. description
    Brentuximab vedotin 1.8 mg/kg every 3 weeks by intravenous (IV) infusion
    id
    FG000
    title
    Brentuximab Vedotin
periods
  1. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        45
      type
      Progressive disease
    2. reasons
      1. group Id
        FG000
        num Subjects
        20
      type
      Adverse Event
    3. reasons
      1. group Id
        FG000
        num Subjects
        12
      type
      Physician Decision
    4. reasons
      1. group Id
        FG000
        num Subjects
        7
      type
      Withdrawal by Subject
    milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        102
      type
      STARTED
    2. achievements
      1. comment
        Number who completed 16 cycles of treatment
        group Id
        FG000
        num Subjects
        18
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        84
      type
      NOT COMPLETED
    title
    Treatment Period
  2. drop Withdraws
    1. reasons
      1. group Id
        FG000
        num Subjects
        7
      type
      Lost to Follow-up
    2. reasons
      1. group Id
        FG000
        num Subjects
        3
      type
      Withdrawal by Subject
    3. reasons
      1. group Id
        FG000
        num Subjects
        2
      type
      Other
    milestones
    1. achievements
      1. comment
        All participants were to be followed after treatment
        group Id
        FG000
        num Subjects
        102
      type
      STARTED
    2. achievements
      1. comment
        Completed survival follow-up due to death \[57\] or study termination by sponsor \[33\]
        group Id
        FG000
        num Subjects
        90
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        12
      type
      NOT COMPLETED
    title
    Follow-up Period
recruitment Details
Enrollment period: Feb 2009 - Aug 2009

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice